<?xml version='1.0' encoding='utf-8'?>
<document id="30568065"><sentence text="Clinical Importance of Drug-Drug Interaction Between Warfarin and Prednisolone and Its Potential Mechanism in Relation to the Niemann-Pick C1-Like 1-Mediated Pathway."><entity charOffset="53-61" id="DDI-PubMed.30568065.s1.e0" text="Warfarin" /><entity charOffset="66-78" id="DDI-PubMed.30568065.s1.e1" text="Prednisolone" /><pair ddi="false" e1="DDI-PubMed.30568065.s1.e0" e2="DDI-PubMed.30568065.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30568065.s1.e0" e2="DDI-PubMed.30568065.s1.e1" /></sentence><sentence text="Warfarin is an anticoagulant drug used to prevent thromboembolic disorders, but its pharmacological effect is affected by co-administered drugs" /><sentence text=" Therefore, careful management of warfarin-related drug-drug interactions (DDIs) is necessary for its safety and effectiveness" /><sentence text=" Recently, intestinal vitamin K1absorption through the Niemann-Pick C1-like 1 (NPC1L1)-mediated pathway was found to affect the pharmacological effect of warfarin"><entity charOffset="154-162" id="DDI-PubMed.30568065.s4.e0" text="warfarin" /></sentence><sentence text=" This study aimed to identify high-frequency warfarin-related DDIs in a clinical setting and elucidate their mechanism(s) in terms of changes in NPC1L1 expression and/or activity" /><sentence text=" Methods and Results: Prednisolone was the most frequently suspected drug in retrospective surveys of medical records of patients who experienced warfarin-related DDIs"><entity charOffset="22-34" id="DDI-PubMed.30568065.s6.e0" text="Prednisolone" /></sentence><sentence text=" Prednisolone significantly increased the international normalized ratio of prothrombin time (PT-INR) values in warfarin-treated patients"><entity charOffset="1-13" id="DDI-PubMed.30568065.s7.e0" text="Prednisolone" /></sentence><sentence text=" To demonstrate the involvement of NPC1L1 in warfarin-prednisolone DDI, we conducted an in vitro vitamin K1uptake assay using NPC1L1-overexpressing cells and found that prednisolone inhibited NPC1L1-mediated vitamin K1uptake"><entity charOffset="169-181" id="DDI-PubMed.30568065.s8.e0" text="prednisolone" /></sentence><sentence text=" Additionally, we found that prednisolone downregulates NPC1L1 in a glucocorticoid receptor α-dependent manner"><entity charOffset="29-41" id="DDI-PubMed.30568065.s9.e0" text="prednisolone" /><entity charOffset="68-82" id="DDI-PubMed.30568065.s9.e1" text="glucocorticoid" /><pair ddi="false" e1="DDI-PubMed.30568065.s9.e0" e2="DDI-PubMed.30568065.s9.e0" /><pair ddi="false" e1="DDI-PubMed.30568065.s9.e0" e2="DDI-PubMed.30568065.s9.e1" /></sentence><sentence text="" /><sentence text="Co-administration of warfarin and prednisolone frequently enhanced the anticoagulant effect of warfarin in a clinical setting"><entity charOffset="21-29" id="DDI-PubMed.30568065.s11.e0" text="warfarin" /><entity charOffset="34-46" id="DDI-PubMed.30568065.s11.e1" text="prednisolone" /><entity charOffset="95-103" id="DDI-PubMed.30568065.s11.e2" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.30568065.s11.e0" e2="DDI-PubMed.30568065.s11.e0" /><pair ddi="false" e1="DDI-PubMed.30568065.s11.e0" e2="DDI-PubMed.30568065.s11.e1" /><pair ddi="false" e1="DDI-PubMed.30568065.s11.e0" e2="DDI-PubMed.30568065.s11.e2" /><pair ddi="false" e1="DDI-PubMed.30568065.s11.e1" e2="DDI-PubMed.30568065.s11.e1" /><pair ddi="false" e1="DDI-PubMed.30568065.s11.e1" e2="DDI-PubMed.30568065.s11.e2" /></sentence><sentence text=" Prednisolone-mediated suppression of NPC1L1 expression and activity could be the mechanism of DDI between warfarin and prednisolone"><entity charOffset="1-13" id="DDI-PubMed.30568065.s12.e0" text="Prednisolone" /><entity charOffset="120-132" id="DDI-PubMed.30568065.s12.e1" text="prednisolone" /><pair ddi="false" e1="DDI-PubMed.30568065.s12.e0" e2="DDI-PubMed.30568065.s12.e0" /><pair ddi="false" e1="DDI-PubMed.30568065.s12.e0" e2="DDI-PubMed.30568065.s12.e1" /></sentence><sentence text=" To manage warfarin therapy, the potential of concomitant drugs to change its anticoagulant effect through NPC1L1-related mechanisms merits consideration" /><sentence text="" /></document>